Analysts: Cornerstone Therapeutics Inc (CRTX.OQ)
CRTX.OQ on NASDAQ Stock Exchange Capital Market
8.51USD
1:06pm EDT
8.51USD
1:06pm EDT
Price Change (% chg)
$0.11 (+1.31%)
$0.11 (+1.31%)
Prev Close
$8.40
$8.40
Open
$8.33
$8.33
Day's High
$8.52
$8.52
Day's Low
$8.30
$8.30
Volume
5,148
5,148
Avg. Vol
19,648
19,648
52-wk High
$10.34
$10.34
52-wk Low
$3.10
$3.10
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Buy | 0.18 | December | 2 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 1 | 1 | 1 | 1 |
| (2) OUTPERFORM | 0 | 0 | 0 | 0 |
| (3) HOLD | 0 | 0 | 0 | 0 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.00 | 1.00 | 1.00 | 1.00 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 1 | 39.06 | 39.06 | 39.06 | -- |
| Quarter Ending Dec-13 | 1 | 38.67 | 38.67 | 38.67 | -- |
| Year Ending Dec-13 | 1 | 151.50 | 151.50 | 151.50 | -- |
| Year Ending Dec-14 | 1 | 163.16 | 163.16 | 163.16 | -- |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 1 | 0.18 | 0.18 | 0.18 | -- |
| Quarter Ending Dec-13 | 1 | 0.20 | 0.20 | 0.20 | -- |
| Year Ending Dec-13 | 1 | 0.58 | 0.58 | 0.58 | -- |
| Year Ending Dec-14 | 1 | 0.46 | 0.46 | 0.46 | -- |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 35.43 | 37.98 | 2.55 | 7.19 |
| Quarter Ending Dec-12 | 36.04 | 34.93 | 1.11 | 3.09 |
| Quarter Ending Sep-12 | 32.00 | 37.53 | 5.53 | 17.27 |
| Quarter Ending Jun-12 | 18.84 | 21.47 | 2.63 | 13.98 |
| Quarter Ending Mar-12 | 20.00 | 22.16 | 2.16 | 10.79 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | 0.13 | 0.09 | 0.04 | 30.77 |
| Quarter Ending Dec-12 | 0.10 | -0.26 | 0.36 | 360.00 |
| Quarter Ending Sep-12 | 0.32 | 0.19 | 0.13 | 40.62 |
| Quarter Ending Jun-12 | -0.02 | 0.11 | 0.13 | -650.00 |
| Quarter Ending Mar-12 | 0.10 | 0.12 | 0.02 | 20.00 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 39.06 | 39.06 | 39.06 | 39.06 | -- |
| Quarter Ending Dec-13 | 38.67 | 38.67 | 38.67 | 38.67 | -- |
| Year Ending Dec-13 | 151.50 | 151.50 | 151.50 | 151.50 | -- |
| Year Ending Dec-14 | 163.16 | 163.16 | 163.16 | 163.16 | -- |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 0.18 | 0.18 | 0.18 | 0.21 | -- |
| Quarter Ending Dec-13 | 0.20 | 0.20 | 0.20 | 0.23 | -- |
| Quarter Ending Dec-13 | 0.58 | 0.58 | 0.58 | 0.68 | -- |
| Quarter Ending Dec-14 | 0.46 | 0.46 | 0.46 | 0.46 | -- |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
| Earnings | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Jefferson Research
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates